How have JSPRW shares performed this year?

Jasper Therapeutics' stock was trading at $0.08 at the beginning of the year. Since then, JSPRW stock has increased by 175.0% and is now trading at $0.22. View the best growth stocks for 2024 here .

How do I buy shares of Jasper Therapeutics?

Shares of JSPRW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:JSPRW

Jasper Therapeutics (JSPRW) Stock Price, News & Analysis

$0.22

0.00 (0.00%)

(As of 07/26/2024 ET)

Compare

Today's Range: $0.22
▼
$0.22
50-Day Range: $0.17
▼
$0.23
52-Week Range: $0.04
▼
$0.38

Volume: N/A
Average Volume: 23,010 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Ownership SEC Filings Short Interest Trends

Get Jasper Therapeutics alerts:

Ad Monument Traders Alliance

NEW AI developed by trader who won 1,129% (in 2 days)

Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...

Click here to see how >>>

About Jasper Therapeutics

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and conditioning regimens for stem cell transplantation. In addition, it is also developing stem cell transplants for rare diseases such as sickle cell disease, fanconi anemia, chronic granulomatous diseases, and GATA2 MDS, and severe combined immunodeficiency. Jasper Therapeutics, Inc. is headquartered in Redwood City, California.

JSPRW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

JSPRW Stock News Headlines

March 9, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: KalVista Pharmaceuticals (KALV), Ayr Wellness (OtherAYRWF) and Jasper Therapeutics (JSPR)

March 9, 2023 | markets.businessinsider.com

Jasper Therapeutics (JSPR) Receives a Buy from Credit Suisse

See More Headlines

Receive JSPRW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:JSPRW
CUSIP: N/A
CIK: 1788028
Web: N/A
Phone: 650-549-1400
Fax: N/A
Employees: 45
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Ronald A. Martell (Age 62)
President, CEO & Director
Comp: $892.45k
Mr. Herbert C. Cross (Age 52)
CFO & Corporate Secretary
Dr. Luca Di Noto Ph.D.
Senior Vice President of Technical Operations
Mr. David Ku M.D.
Vice President of Corporate Development, Portfolio Strategy & Management
Mr. Matthew Ford
Vice President of Human Resources
Dr. Wendy Pang M.D.
Ph.D., Senior Vice President of Research & Translational Medicine
Dr. Edwin Jonathan Tucker M.D. (Age 52)
Chief Medical Officer
Ms. Patricia Carlos
Senior Vice President of Regulatory Affairs & Quality

Key Competitors

View All Competitors

JSPRW Stock Analysis - Frequently Asked Questions

How have JSPRW shares performed this year?: Jasper Therapeutics' stock was trading at $0.08 at the beginning of the year. Since then, JSPRW stock has increased by 175.0% and is now trading at $0.22.
View the best growth stocks for 2024 here.
How do I buy shares of Jasper Therapeutics?: Shares of JSPRW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.